Steps to rebuilding pharma R&D efficiency: “The Exupéry Principle” for medicinal chemistry
The efficiency of pharmaceutical R&D is declining.  That much is not in doubt: record ...

Chocolate-flavoured Poison: Like red wine and debt, the company-building model of biotech investing tastes good but kills you eventually
The most dangerous imperatives are those that you actually like.  Hearing, and half believing, ...